A tourniquet is often used during limb surgery to minimize surgical bleeding and to keep the surgical field dry. It is, however, sometimes accompanied with so-called tourniquet pain, which is characterized by gradual onset and a dull aching sensation at the site of the tourniquet or distal extremity. Tourniquet pain is often accompanied by a progressive increase in systemic arterial pressure, which follows a time course parallel to the intensity of the tourniquet pain (1) . Tourniquet-induced hypertension, defined as a more than 30% increase in either systolic or diastolic arterial pressure in patients with a tourniquet inflated for at least an hour (2) (3) (4) , may develop despite otherwise adequate anesthesia for the surgical procedure. It is more common under general anesthesia (53%-67%) (3, 4) than spinal anesthesia (2.7%-6.7%) (3, 4) and occurs more often in lower-limb surgery than in upperlimb surgery (3).
Segerdahl et al. (5) reported that IV ketamine 0.1 mg/kg reduced tourniquet pain in healthy awake adult volunteers. However, its mechanism was not discussed in detail. There are few reports on the relationship between ketamine and tourniquet pain or tourniquet-induced arterial pressure increase. Tourniquet inflation activates C fibers (6, 7) . N-methyl-daspartic acid (NMDA) receptor activation is involved in the mechanism of central sensitization induced by repeated nociceptive C-fiber afferent input (8, 9) . The mechanism of tourniquet pain and tourniquetinduced systemic arterial pressure increase has not been elucidated. We therefore hypothesized that tourniquet-induced systemic arterial pressure increase might be related to NMDA receptor activation by the peripheral noxious input from the affected limb and that ketamine, an NMDA receptor antagonist, might Presented in part at the annual meeting of the American Society of Anesthesiologists, Dallas, TX, October, 1999.
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We investigated the effect of preoperative small and large doses of IV ketamine on systemic arterial pressure and heart rate changes in patients under general anesthesia undergoing knee surgery with a tourniquet.
Methods
The study protocol was approved by our ethical committee and was performed in a randomized, doubleblinded, prospective fashion. Written informed consent was obtained from each patient. Eighty-five patients, ASA physical status class I or II, aged 14 to 68 yr, under general anesthesia undergoing knee surgery with a tourniquet, were included in this study. Patients with hypertension, ischemic heart disease, and diabetes mellitus were excluded. The participating patients were randomly assigned into one of the three groups by using a random numbering card: Large Ketamine group (n ϭ 28), Small Ketamine group (n ϭ 28), and Control group (n ϭ 29).
After oral diazepam 5 mg and ranitidine 150 mg was given 2 h before, anesthesia was induced with thiamylal 5 mg/kg IV, and the trachea was intubated after vecuronium 0.1 mg/kg IV. Ventilation was controlled with a tidal volume of 10 mL/kg and a respiratory rate of 10 breaths/min. Anesthesia was maintained with sevoflurane 1.5%-2.5% and N 2 O 66% in oxygen. End-tidal sevoflurane concentrations after anesthetic induction were adjusted so that arterial pressure and heart rate after anesthetic induction and before tourniquet inflation were within 20% of their preinduction values. Thereafter, the end-tidal sevoflurane concentration was maintained steady during the study period. During anesthesia, noninvasive arterial pressure, electrocardiograph, and heart rate were monitored. Also, the concentrations of end-tidal anesthetic gases were monitored by an anesthetic gas monitoring system (5250 RGM; Datex-Ohmeda, Helsinki, Finland). When systolic arterial pressure increased to more than 200 mm Hg, fentanyl 100 g, nicardipine 1 mg, or both were given IV.
At least 10 min before skin incision and tourniquet inflation, a specific solution was given IV for each group; namely, the solution containing ketamine 1.0 mg/kg was given in the Large Ketamine group, the solution containing ketamine 0.25 mg/kg was given in the Small Ketamine group, and the solution containing only physiological saline was given in the Control group by an attending anesthesiologist who was blinded to the grouping. Each solution, 10 mL in volume, was prepared in a 10-mL syringe the morning of each surgery by the anesthesiologist responsible for patient grouping. After skin incision, tourniquet inflation was performed at the thigh level by using 300 mm Hg of pressure. Arterial pressure and heart rate were determined at 0, 10, 20, 30, 40, 50, and 60 min after the start of tourniquet inflation and after tourniquet deflation.
After surgery, the anesthetic was terminated, and the patients' tracheas were extubated after reversing neuromuscular blockade by using atropine 0.02 mg/kg IV and neostigmine 0.05 mg/kg IV. On the first postoperative day, patients were interviewed about ketamine-related psychological experiences such as hallucination and nightmares. Data from the patients in whom the tourniquet was deflated within 60 min after the start of tourniquet inflation, who needed IV nicardipine, or who needed IV fentanyl during the study period were excluded from the study.
Demographic data were expressed as mean Ϯ se and compared among the three groups by using analysis of variance (ANOVA). Hemodynamic changes were statistically compared with their baseline values and among the three groups by using two-way repeated-measures ANOVA. The percentages of patients who developed tourniquet-induced hypertension, defined as more than a 30% increase in systolic arterial pressure (2-4) during tourniquet inflation, were compared among the three groups. A personal computer software package, SPSS version 5.0 (SPSS Inc., Chicago, IL), was used in the statistical analysis. P Ͻ 0.05 was considered statistically significant.
Results
Four patients in the Large Ketamine group, two patients in the Small Ketamine group, and three patients in the Control group were excluded from the study because the tourniquet was deflated within 60 min after the start of tourniquet inflation. No patient was excluded from the study because of an increased systolic arterial pressure 200 mm Hg or more during tourniquet inflation. The statistical analyses were performed with the remaining patients' data.
There were no significant differences in the patients' demographic data and mean end-tidal sevoflurane concentrations during the study period among the three groups (Table 1) . Baseline arterial pressure and heart rate were not different among the three groups (Table 1 ). In the Large Ketamine and Small Ketamine groups, systolic and diastolic arterial pressures were not changed during the study period, but in the Control group, systolic arterial pressure was significantly increased at 40, 50, and 60 min, and diastolic arterial pressure was significantly increased at 50 and 60 min after the start of tourniquet inflation ( Fig. 1) (P Ͻ 0.05) . In all groups, heart rate was not changed significantly during tourniquet inflation. The Control group had a significantly larger percentage of patients who developed tourniquet-induced hypertension than the Large and Small Ketamine groups (P Ͻ 0.01) (Fig. 2) .
All patients emerged from anesthesia and their tracheas were extubated within 15 min after the end of surgery. No patient reported nightmares or psychological problems after anesthesia.
Discussion
The results of this study showed that a preoperative small dose of IV ketamine significantly prevented a systemic arterial pressure increase during prolonged tourniquet inflation in patients under general anesthesia.
The mechanism of the tourniquet-induced arterial pressure increase has not been investigated in detail, but the results of this study suggest that it may include NMDA receptor activation. Indeed, the NMDA receptor activation produced increases in mean arterial pressure (10) , and the NMDA receptor antagonism blocked the cardiovascular response in animals (10 -12) . Tourniquet-induced arterial pressure increases and pain subsides within a few minutes after tourniquet deflation. Perhaps tourniquet-induced hypertension and pain can be caused by acute-onset hyperesthesia via central neuronal plasticity, but more confirmation is needed.
Tetzlaff et al. (13) showed that tourniquet-induced arterial pressure increases correlate with the activation of the sympathetic nervous system, as measured by power spectral heart rate analysis. An increase in plasma norepinephrine levels was related to the tourniquet-induced arterial pressure increase under 
Data are presented as mean Ϯ se unless otherwise noted. Tourniquet ϭ duration of tourniquet inflation; ETsevo ϭ end-tidal sevoflurane concentration; AP ϭ arterial pressure (systolic/diastolic). * P Ͻ 0.02 vs Large-Ketamine and Small-Ketamine groups, respectively.
Figure 1.
Hemodynamic changes in the three groups during and after tourniquet inflation. In the Large Ketamine and Small Ketamine groups, systolic and diastolic arterial pressures were not changed during tourniquet inflation, but in the Control group systolic arterial pressures were significantly increased at 40, 50, and 60 min, and diastolic arterial pressures were significantly increased at 50 and 60 min after the start of tourniquet inflation compared with baseline values (P Ͻ 0.05). Heart rate was not changed in all the groups. SAP ϭ systolic arterial pressure; DAP ϭ diastolic arterial pressure; HR ϭ heart rate; Before ϭ before the start of tourniquet inflation; After ϭ after tourniquet deflation. general anesthesia (14) . In addition, NMDA receptor antagonism decreased biogenic amine release during muscle contraction (12) . Catecholamine release after the activation of the sympathetic nervous system may contribute to the increase in systemic arterial pressure during prolonged tourniquet inflation. Tourniquet-induced arterial pressure increase may develop despite otherwise adequate anesthesia. It is difficult to treat hypertension when tourniquetinduced arterial pressure increase occurs, especially in patients with cardiovascular problems, such as essential hypertension and ischemic heart diseases; with neurological diseases, such as intracranial aneurysms and increased intracranial pressure status; or with glaucoma. In such patients, IV ketamine before tourniquet inflation and skin incision is expected to prevent tourniquet-induced arterial pressure increase. In this study, we used two ketamine doses, 1.0 mg/kg and 0.25 mg/kg, to compare the dose-response relation of ketamine on the arterial pressure changes. We found that the Small-Dose Ketamine group did not experience an arterial pressure increase, nor did the Large-Dose Ketamine group. Preoperative ketamine 0.15 mg/kg IV showed a preemptive analgesic effect in patients undergoing open cholecystectomy (15) . It was expected that patients in the Large and Small Ketamine groups would have less wound pain after surgery. Psychotomimetic reaction is the most serious side effect limiting the clinical usefulness of ketamine (16) . However, none of our patients reported a psychotomimetic effect after surgery.
There are two limitations in this study. First, because this study was performed under general anesthesia, the effect of ketamine on tourniquet-induced pain itself and the causal relationship between tourniquet-induced pain and the incidence of tourniquet-induced arterial pressure increase could not be evaluated. Second, the depth of anesthesia might not be identical among the patients because we did not use a bispectral index or processed electroencephalogram monitor to ensure similar anesthetic depth among the patients. However, we determined the maintaining end-tidal sevoflurane concentration by arterial pressure responses to anesthesia. There was no significant differences in end-tidal sevoflurane concentration during the study period and arterial pressure before tourniquet inflation among the three groups (Table 1) . We believe that small differences in end-tidal sevoflurane concentrations did not influence the results significantly. The next protocol to elucidate the further mechanisms of tourniquet-induced arterial pressure increase should be focused on when and how ketamine should be applied and on the correlation between tourniquet-induced arterial pressure increase and pain.
In conclusion, preoperative IV ketamine 0.25 mg/kg or more significantly prevented tourniquet-induced arterial pressure increase in patients under general anesthesia undergoing knee surgery.
